Mass production of recombinant proteins using yeast cell "factories" needs methanol, a compound that requires safe handling, carries the risk of catching fire, and sometimes produces harmful ...

AAA Bio’s recombinant proteins, offering high purity, consistency, and reliability for advancing research in drug ...

Congenital thrombotic thrombocytopenic purpura (TTP) results from severe hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and standard therapy (plasma-derived ...

Recombinant DNA (rDNA) has many uses in the society of today, from research and biotechnology to the medicine stocked on the shelves of pharmacies. The ability to manipulate the creation of DNA with ...

Antibody engineering and production are essential tools in drug discovery, providing powerful and specific therapeutics and diagnostic/prognostic materials for various diseases. Antibodies are ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

A recombinant replacement for the ADAMTS13 protein (Adzynma) missing in congenital thrombotic thrombocytopenic purpura (TTP) restored levels and reduced acute TTP events, according to interim trial ...

Notification: The Recombinant Protein Production and Characterization (RPPC) Core has undergone reorganization as of January 2026. The previous Macromolecular X-Ray Crystallography Core has been ...

Church based education improved recombinant zoster vaccine knowledge and intent in vulnerable adults, read more.

Our animal-origin free recombinant proteins and enzymes portfolio, developed with Dyadic, augments Fermbox’s strategy ...